Dulaglutide 1.5 MG/ML

DRUG2 trials

Sponsors

Shanghai Zhongshan Hospital, Zagazig University

Conditions

Obese DiabeticsObese Non DiabeticType 2 Diabetes

Phase 3

Comparative Study of Different Weekly GLP-1 Receptor Agonists Among Diabetic and Non-Diabetic Patients: Clinical Trial

CompletedNCT07820111

Zagazig UniversityObese Diabetics, Obese Non Diabetic

Start: 2025-10-18End: 2026-03-17Updated: 2026-09-15

Unknown Phase

Effect of Dulaglutide on Glycemic Variability in Patients With Type 2 Diabetes

CompletedNCT04374578

Shanghai Zhongshan HospitalType 2 Diabetes

Start: 2020-05-08End: 2021-06-30Updated: 2022-03-31